Australian Clinical Labs Limited (ASX:ACL) is an Australian private provider of pathology services. The company has 86 accredited laboratories performing a diverse range of pathology tests each year for a range of clients including doctors, specialists, patients, hospitals and corporate clients. ACL is one of the largest private hospital pathology businesses nationally.
The Australian Clinical Labs Ltd (ASX: ACL) share price is up more than 5% after the company upgraded first-half guidance expectations.
